Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer

SIMPLE SUMMARY: Small-cell lung cancer (SCLC) is an aggressive malignancy with a high risk of recurrence and poor prognosis despite aggressive treatment. The use of immunotherapy has revolutionized the therapeutic landscape of SCLC with the introduction of novel, effective treatment options. Immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Selina K., Iams, Wade T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865814/
https://www.ncbi.nlm.nih.gov/pubmed/33572705
http://dx.doi.org/10.3390/cancers13030506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865814/
https://www.ncbi.nlm.nih.gov/pubmed/33572705
http://dx.doi.org/10.3390/cancers13030506

Ejemplares similares